Alexander Martinez-Fundichely

Alexander Martinez-Fundichely

Auto-generated profile, based on publicly available information

Alexander Martinez-Fundichely

Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in Science
Verified
Journal Article
Closed access
FTFanying Tang
Fanying Tang
DXDuo Xu
Duo Xu
SWShangqian Wang
Shangqian Wang
CWChen Khuan Wong
Chen Khuan Wong
AMAlexander Martinez-Fundichely
Alexander Martinez-Fundichely
EKEkta Khurana
Ekta Khurana
In castration-resistant prostate cancer (CRPC), the loss of androgen receptor (AR) dependence leads to clinically aggressive tumors with few therapeutic options. We used ATAC-seq (assay for transposase-accessible chromatin sequencing), RNA-seq, and DNA sequencing to investigate 22 organoids, six patient-derived xenografts, and 12 cell lines. We identified the well-characterized AR-dependent and neuroendocrine subtypes, as well as two AR-negative/low groups: a Wnt-dependent subtype, and a stem cell–like (SCL) subtype driven by activator protein–1 (AP-1) transcription factors. We used transcriptomic signatures to classify 366 patients, which showed that SCL is the second most common subtype of CRPC after AR-dependent. Our data suggest that AP-1 interacts with the YAP/TAZ and TEAD proteins to maintain subtype-specific chromatin accessibility and transcriptomic landscapes in this group. Together, this molecular classification reveals drug targets and can potentially guide therapeutic decisions.

20 February 2020 in Cell
Verified
Journal Article
Closed access
SKSushant Kumar
Sushant Kumar
JWJonathan Warrell
Jonathan Warrell
SLShantao Li
Shantao Li
PMPatrick D. McGillivray
Patrick D. McGillivray
WMWilliam Meyerson
William Meyerson
MGMark B. Gerstein
Mark B. Gerstein

16 December 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
VAVanessa Aguiar-Pulido
Vanessa Aguiar-Pulido
PWPaul Wolujewicz
Paul Wolujewicz
AMAlexander Martinez-Fundichely
Alexander Martinez-Fundichely
EEEran Elhaik
Eran Elhaik
GTGaurav Thareja
Gaurav Thareja
MRM. Elizabeth Ross
M. Elizabeth Ross
Significance: Genetic investigations of most structural birth defects, including spina bifida (SB), congenital heart disease, and craniofacial anomalies, have been underpowered for genome-wide association studies because of their rarity, genetic heterogeneity, incomplete penetrance, and environmental influences. Our systems biology strategy to investigate SB predisposition controls for population stratification and avoids much of the bias inherent in candidate gene searches that are pervasive in the field. We examine both protein coding and noncoding regions of whole genomes to analyze sequence variants, collapsed by gene or regulatory region, and apply machine learning, gene enrichment, and pathway analyses to elucidate molecular pathways and genes contributing to human SB.

23 October 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ELEric Minwei Liu
Eric Minwei Liu
AMAlexander Martinez-Fundichely
Alexander Martinez-Fundichely
RBRajesh Bollapragada
Rajesh Bollapragada
MSMaurice Spiewack
Maurice Spiewack
EKEkta Khurana
Ekta Khurana
Most mutations in cancer genomes occur in the non-coding regions with unknown impact on tumor development. Although the increase in the number of cancer whole-genome sequences has revealed numerous putative non-coding cancer drivers, their information is dispersed across multiple studies making it difficult to understand their roles in tumorigenesis of different cancer types. We have developed CNCDatabase, Cornell Non-coding Cancer driver Database (https://cncdatabase.med.cornell.edu/) that contains detailed information about predicted non-coding drivers at gene promoters, 5′ and 3′ UTRs (untranslated regions), enhancers, CTCF insulators and non-coding RNAs. CNCDatabase documents 1111 protein-coding genes and 90 non-coding RNAs with reported drivers in their non-coding regions from 32 cancer types by computational predictions of positive selection using whole-genome sequences; differential gene expression in samples with and without mutations; or another set of experimental validations including luciferase reporter assays and genome editing. The database can be easily modified and scaled as lists of non-coding drivers are revised in the community with larger whole-genome sequencing studies, CRISPR screens and further experimental validations. Overall, CNCDatabase provides a helpful resource for researchers to explore the pathological role of non-coding alterations in human cancers.

30 June 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
EWElissa W. P. Wong
Elissa W. P. Wong
MSMerve Sahin
Merve Sahin
RYRui Yang
Rui Yang
ULUkJin Lee
UkJin Lee
DLDan Li
Dan Li
PCPing Chi
Ping Chi
Transposable elements (TEs) are abundant in the human genome, and they provide the source for genetic and functional diversity. Previous studies have suggested that TEs are repressed by DNA methylation and chromatin modifications. Here through integrating transcriptome and 3D genome architecture studies, we showed that haploinsufficient loss of NIPBL selectively activates alternative promoters (altPs) at the long terminal repeats (LTRs) of the TE subclasses. This activation occurs through the reorganization of topologically associating domain (TAD) hierarchical structures and the recruitment of proximal enhancers. These observations indicate that TAD hierarchy restricts transcriptional activation of LTRs that already possess open chromatin features. Perturbation of hierarchical chromatin topology can lead to co-option of LTRs as functional altPs, driving aberrant transcriptional activation of oncogenes. These data uncovered a new layer of regulatory mechanisms of TE expression and posit TAD hierarchy dysregulation as a new mechanism for altP-mediated oncogene activation and transcriptional diversity in cancer.

12 March 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
SKSushant Kumar
Sushant Kumar
JWJonathan Warrell
Jonathan Warrell
SLShantao Li
Shantao Li
PMPatrick D. McGillivray
Patrick D. McGillivray
WMWilliam Meyerson
William Meyerson
MGMark B. Gerstein
Mark B. Gerstein
The Pan-cancer Analysis of Whole Genomes (PCAWG) project provides an unprecedented opportunity to comprehensively characterize a vast set of uniformly annotated coding and non-coding mutations present in thousands of cancer genomes. Classical models of cancer progression posit that only a small number of these mutations strongly drive tumor progression and that the remaining ones (termed “putative passengers”) are inconsequential for tumorigenesis. In this study, we leveraged the comprehensive variant data from PCAWG to ascertain the molecular functional impact of each variant. The impact distribution of PCAWG mutations shows that, in addition to high- and low-impact mutations, there is a group of medium-impact putative passengers predicted to influence gene activity. Moreover, the predicted impact relates to the underlying mutational signature: different signatures confer divergent impact, differentially affecting distinct regulatory subsystems and gene categories. We also find that impact varies based on subclonal architecture (i.e., early vs. late mutations) and can be related to patient survival. Finally, we note that insufficient power due to limited cohort sizes precludes identification of weak drivers using standard recurrence-based approaches. To address this, we adapted an additive effects model derived from complex trait studies to show that aggregating the impact of putative passenger variants (i.e. including yet undetected weak drivers) provides significant predictability for cancer phenotypes beyond the PCAWG identified driver mutations (12.5% additive variance). Furthermore, this framework allowed us to estimate the frequency of potential weak driver mutations in the subset of PCAWG samples lacking well-characterized driver alterations.